Doximity Inc (DOCS) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Doximity Inc stock (DOCS) is currently trading at $24.18. Doximity Inc PE ratio is 20.45. Doximity Inc PS ratio (Price-to-Sales) is 7.19. Analyst consensus price target for DOCS is $39.55. WallStSmart rates DOCS as Moderate Buy.
- DOCS PE ratio analysis and historical PE chart
- DOCS PS ratio (Price-to-Sales) history and trend
- DOCS intrinsic value — DCF, Graham Number, EPV models
- DOCS stock price prediction 2025 2026 2027 2028 2029 2030
- DOCS fair value vs current price
- DOCS insider transactions and insider buying
- Is DOCS undervalued or overvalued?
- Doximity Inc financial analysis — revenue, earnings, cash flow
- DOCS Piotroski F-Score and Altman Z-Score
- DOCS analyst price target and Smart Rating
Doximity Inc
📊 No data available
Try selecting a different time range
DOCS Intrinsic Value Analysis for Value Investors
Benjamin Graham Formula · Doximity Inc (DOCS)
DOCS trades 221% above its Graham fair value of $8.09, indicating the stock may be overvalued at current levels.
Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.
Smart Analysis
Doximity Inc (DOCS) · 10 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in peg ratio, return on equity, operating margin. Concerns around eps growth. Overall metrics suggest strong investment potential with favorable risk/reward.
Doximity Inc (DOCS) Key Strengths (6)
Growing significantly faster than its price suggests
Keeps $39 of every $100 in revenue after operating costs
Keeps $38 of every $100 in revenue as net profit
93.17% of shares held by major funds and institutions
Every $100 of equity generates $24 in profit
Mid-cap company balancing growth potential with stability
Supporting Valuation Data
Doximity Inc (DOCS) Areas to Watch (4)
Earnings declining -16.20%, profits shrinking
Premium valuation at 7.2x annual revenue
Premium pricing at 4.6x book value
Modest revenue growth at 9.80%
Supporting Valuation Data
Doximity Inc (DOCS) Detailed Analysis Report
Overall Assessment
This company scores 66/100 in our Smart Analysis, earning a B- grade. Out of 10 metrics analyzed, 6 register as strengths (avg 9.3/10) while 4 fall into concern territory (avg 3.0/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on PEG Ratio, Operating Margin, Profit Margin. Valuation metrics including PEG Ratio (0.67) suggest the stock is attractively priced. Profitability is solid with Return on Equity at 23.80%, Operating Margin at 38.90%, Profit Margin at 37.50%.
The Bear Case
The primary concerns are EPS Growth, Price/Sales, Price/Book. Some valuation metrics including Price/Sales (7.19), Price/Book (4.60) suggest expensive pricing. Growth concerns include Revenue Growth at 9.80%, EPS Growth at -16.20%, which may limit upside.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether EPS Growth improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 23.80% currently healthy but needing to be sustained. Third, growth sustainability, with Revenue Growth at 9.80% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a moderate-to-high risk investment. The weight of evidence leans positive, with more strengths than concerns. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Mixed fundamentals with both positives (PEG Ratio, Operating Margin) and negatives (EPS Growth, Price/Sales). A cautious approach is warranted. Monitor for improvement in weak areas before increasing conviction.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
DOCS Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
DOCS's Price-to-Sales ratio of 7.19x trades at a deep discount to its historical average of 15.39x (6th percentile). The current valuation is 87% below its historical high of 55.68x set in Sep 2021, and 25% above its historical low of 5.75x in Feb 2026. Over the past 12 months, the PS ratio has compressed from ~16.5x as trailing revenue scaled faster than the stock price.
Compare DOCS with Competitors
Top HEALTH INFORMATION SERVICES stocks by market cap
Compare any two stocks →WallStSmart Analysis Synopsis
Data-driven financial summary for Doximity Inc (DOCS) · HEALTHCARE › HEALTH INFORMATION SERVICES
The Big Picture
Doximity Inc is a mature, profitable business with steady cash generation. Revenue reached 638M with 10% growth year-over-year. Profit margins are strong at 37.5%, reflecting pricing power and operational efficiency.
Key Findings
ROE of 23.8% means the company generates strong returns on shareholder equity. Above 20% is considered top-tier.
Profit margin of 37.5% and operating margin of 38.9% demonstrate strong pricing power and operational efficiency.
What to Watch Next
Sector dynamics: monitor HEALTH INFORMATION SERVICES industry trends, competitive moves, and regulatory changes that could impact Doximity Inc.
Bottom Line
Doximity Inc is a well-established business delivering consistent profitability with 37.5% margins. The growth phase may be slowing, but strong cash generation and operational efficiency make it suitable for investors seeking reliability over excitement.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About Doximity Inc(DOCS)
NYSE
HEALTHCARE
HEALTH INFORMATION SERVICES
USA
Doximity, Inc. (Ticker: DOCS) is a U.S. healthcare technology company that operates a digital platform tailored for medical professionals. The company’s cloud-based network provides secure communication and collaboration tools, telemedicine services, clinical workflow solutions, and access to medical news, research, and career-management features for physicians, nurse practitioners, physician assistants, and other clinicians. Headquartered in San Francisco, California, Doximity’s Class A common stock trades on the New York Stock Exchange under the ticker DOCS.